Literature DB >> 689489

Acquired antithrombin III deficiency in patients with glomerular proteinuria.

E Thaler, E Balzar, H Kopsa, W F Pinggera.   

Abstract

Antithrombin III (AT II/III) was determined immunologically and by means of a heparin cofactor assay in plasma samples and 24-hour urine of 15 patients with various degrees of proteinuria, being predominantly of glomerular origin. In urine the AT II/III concentrations were significantly correlated to the concentrations of albumin, plasminogen and IgG. One third of the patients had AT II/III plasma levels below the normal range. The plasma levels showed a significant inverse correlation to the AT II/III and albumin clearance rates. Similarily, the plasminogen concentrations in plasma were decreased in two thirds of the patients, being inversely correlated to the renal plasminogen clearance values. It is proposed that AT II/III deficiency in the nephrotic syndrome is an important pathogenetic factor in venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 689489     DOI: 10.1159/000214268

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  10 in total

1.  Upper limb venous thrombosis complicating amyloidosis.

Authors:  W Dickey; M E Callender; E E Mayne
Journal:  Ir J Med Sci       Date:  1986-12       Impact factor: 1.568

2.  Acquired alpha 2 antiplasmin deficiency in glomerular proteinuria.

Authors:  D A Taberner; A J Ralston; P Ackrill
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

Review 3.  Hypercoagulability in the Nephrotic syndrome.

Authors:  K Andrassy; E Ritz; J Bommer
Journal:  Klin Wochenschr       Date:  1980-10-01

4.  Haemostatic measurements in childhood nephrotic syndrome.

Authors:  A T Elidrissy; M B Abdurrahman; H M Bahakim; M D Jones; A M Gader
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

Review 5.  Arterial thrombosis in the nephrotic syndrome.

Authors:  I H Fahal; P McClelland; C R Hay; G M Bell
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

6.  Deficiency of antithrombin III in children with hemolytic-uremic syndrome.

Authors:  B Roth; T von Lilien; B Busch; A Gillor; M Bulla
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

7.  Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus.

Authors:  M P Jarrett; D Green; C H Ts'ao
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

8.  [Antithrombin III changes following myocardial infarct].

Authors:  G Oehler; M Büdinger; D Heinrich; T Schöndorf
Journal:  Klin Wochenschr       Date:  1984-09-03

9.  Antithrombin III in children with various renal diseases.

Authors:  H Fukui; A Taniguchi; S Sakamoto; S Kawahara; T Matsunaga; K Taira; S Tanaka; H Kamitsuji
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

Review 10.  Hemostatic complications in renal disorders of the young.

Authors:  M Andrew; L A Brooker
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.